Stay updated on TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page.

Latest updates to the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, signaling a minor update to the page's template or documentation rather than substantive changes to the study information.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, indicating a new deployment/version of the page. This appears to be an internal metadata update with no visible changes to the study details or user-facing content.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a software update to the ClinicalTrials.gov page with no evident changes to the study information.SummaryDifference0.1%

- Check54 days agoChange DetectedThe study page now indicates that no new participants are being recruited. New help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, the Intervention/Treatment label formatting was adjusted, and the revision note was updated to v3.6.0.SummaryDifference0.5%

- Check61 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5 on the study page. This indicates a minor maintenance update to the page metadata rather than changes to study data.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision: v3.5.4 replaces v3.5.3 on the page, indicating a minor page version update. The update does not specify changes to study details or results.SummaryDifference0.1%

Stay in the know with updates to TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page.